comparing glp 1 drugs comparison of agonists GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? developed bundle cultivating targeted restoration across the Gut New oral GLP-1 drug delivers

[DOI] [PubMed] [Google Scholar] 39.Blundell J., Finlayson G., Axelsen M., Flint A., Gibbons C., Kvist T., Hjerpsted J.B

doi: 10.1111/dom.14032

Here's what the evidence actually shows and what it doesn't

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 119.00 per year only 9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

It was FDA-approved for Type 2 diabetes, and physicians frequently prescribe it off-label for weight management as well

The results showed high heterogeneity of weight loss from the baseline weight between individuals even at the highest dose of tirzepatide 38.4 to 9.0 kg and mean 22.1 kg